Piloting an Insomnia Treatment in Patients With Ulcerative Colitis
Sponsor: Dartmouth-Hitchcock Medical Center • ClinicalTrials.gov ID: NCT07428629
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
The goal of this clinical trial is to learn if telehealth-based Cognitive Behavioral Therapy for Insomnia (CBT-I) adapted for Ulcerative Colitis (UC) works to treat insomnia in adults with UC. The main questions it aims to answer are: * Is telehealth-based CBT-I adapted for UC feasible and acceptable to participants? * Does CBT-I for UC impact insomnia severity and sleep continuity? Participants will: * Answer questionnaires online before and after treatment * Complete an online daily sleep diary before, during, and after treatment * Participate in 5 telehealth treatment visits over 7-8 weeks * Participate in 5-10-minute phone calls between treatment visits
Interventions
-
CBT-I UC
(Behavioral)
This treatment is designed to help participants make changes to behavior patterns and thoughts that contribute to insomnia.
Eligibility criteria
Conditions
Locations
- Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record